PNAS Therapeutics

AmacaThera

The company develops injectable hydrogel drug delivery platforms for pharmaceutical partners to provide sustained post-surgical pain management and localised therapeutic release.

Aera Therapeutics

This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.

Optimeos Life Sciences

This company develops nanoparticle drug delivery systems and long-acting injectables for pharmaceutical partners to enable targeted intracellular delivery of genetic medicines and proteins.

NaDeNo

This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.

Drug Delivery

This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Cytonus Therapeutics

This biotechnology company develops engineered cell-based delivery platforms to transport therapeutic payloads for treating cancers, inflammatory diseases, and cognitive disorders.

Nuntius Therapeutics

This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.